Project Details
Description
The aim of this study is to investigate the use of fullerene nanoparticles as an opportunistic adjuvant/delivery agent for synthetic peptide vaccine development and to test fullerene antioxidant activity in thyrocytes’ acquired from patients with autoimmune thyroiditis.
| Status | Finished |
|---|---|
| Effective start/end date | 1/05/19 → 31/03/20 |
Total Funding
- Riga Stradins University: €20,000.00
Keywords
- fullerene nanoparticles
Field of Science
- 3.1 Basic medicine
Smart Specialization Area
- Biomedicine, medical technologies and biotechnology
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.